Hualan Biological Bacterin Inc. (301207.SZ)
CNY 18.51
(0.16%)
CNY 18.51
(0.16%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.02 Billion CNY | 7.37% |
| 2022 | 741.88 Million CNY | 4.88% |
| 2021 | 789.73 Million CNY | -25.31% |
| 2020 | 1.11 Billion CNY | 87.59% |
| 2019 | 444.04 Million CNY | 44.31% |
| 2018 | 306.25 Million CNY | 3591.19% |
| 2017 | 12.21 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 282.27 Million CNY | 2355.24% |
| 2024 Q1 | 1.4 Million CNY | -74.24% |
| 2024 Q2 | -12.51 Million CNY | -115.7% |
| 2023 Q1 | 76.94 Million CNY | -63.61% |
| 2023 FY | - CNY | 7.37% |
| 2023 Q4 | 274.65 Million CNY | -58.75% |
| 2023 Q3 | 665.81 Million CNY | 6652.68% |
| 2023 Q2 | -10.16 Million CNY | -113.21% |
| 2022 Q3 | 226.06 Million CNY | -43.52% |
| 2022 Q2 | 400.26 Million CNY | 2460.87% |
| 2022 Q1 | -16.95 Million CNY | -106.65% |
| 2022 FY | - CNY | 4.88% |
| 2022 Q4 | 211.46 Million CNY | -6.46% |
| 2021 Q1 | 10.98 Million CNY | -98.4% |
| 2021 Q4 | 255.03 Million CNY | -64.78% |
| 2021 Q3 | 724.1 Million CNY | 1529.57% |
| 2021 Q2 | -50.65 Million CNY | -560.93% |
| 2021 FY | - CNY | -25.31% |
| 2020 FY | - CNY | 87.59% |
| 2020 Q4 | 688.71 Million CNY | 22.41% |
| 2020 Q3 | 562.62 Million CNY | 1881.33% |
| 2020 Q2 | -31.58 Million CNY | -1208.28% |
| 2020 Q1 | -2.41 Million CNY | 0.0% |
| 2019 FY | - CNY | 44.31% |
| 2018 FY | - CNY | 3591.19% |
| 2017 FY | - CNY | 0.0% |